Matt Pierce
Director/Miembro de la Junta en LIfT BioSciences Ltd. .
Perfil
Matt Pierce is currently working as an Investment Director at Downing Ventures since 2019.
He is also a Non Executive Director at Qkine Ltd.
since 2022, TidalSense Ltd.
since 2021, and LIfT BioSciences Ltd.
since 2019.
Mr. Pierce completed his undergraduate degree at The University of Edinburgh in 2012.
Cargos activos de Matt Pierce
Empresas | Cargo | Inicio |
---|---|---|
Downing Ventures
Downing Ventures Investment ManagersFinance Downing Ventures (Downing Ventures) is an independent venture capital firm founded in 1986. The firm is headquartered in London. | Inversor de Capital Privado | 01/06/2021 |
Qkine Ltd.
Qkine Ltd. Pharmaceuticals: OtherHealth Technology Qkine Ltd. provides growth factors and bioactive proteins for use in stem cell science and regenerative medicine applications. Its products include Activin A and FGF2. The firm specializes in protein purification, organoids, cytokines, and protein-engineering. The company was founded by Marko Hyvonen and Catherine Elton in 2016 and is headquartered in Cambridge, the United Kingdom. | Director/Miembro de la Junta | 01/11/2022 |
LIfT BioSciences Ltd.
LIfT BioSciences Ltd. Miscellaneous Commercial ServicesCommercial Services LIfT BioSciences Ltd. is a pre-clinical stage biotech company based in Brighton, UK. LIfT BioSciences is developing a first-in-class alpha neutrophil cell therapy called N-Lift, which is produced from a patented process using exceptional stem cells, a proprietary enhancement media, and genetic engineering. The therapy is designed to destroy solid tumors both directly and indirectly by turning the tumor microenvironment against the tumor and recruiting the rest of the immune system to destroy it. The British company is working with a range of pharmaceutical license partners across oncology, immunology, neurology, and AMR to develop a portfolio of immune-modulatory alpha neutrophils for treating a range of therapeutic indications, including solid tumors. The company's goal is to deliver complete remission in high unmet need solid tumors before the decade is out. The company was founded in 2014 by Alexander William Blyth, who was inspired to create the company after his mother passed away from pancreatic cancer. | Director/Miembro de la Junta | 01/12/2019 |
TidalSense Ltd.
TidalSense Ltd. Medical SpecialtiesHealth Technology Part of Gas Sensing Solutions Ltd., Cambridge Respiratory Innovations Ltd. develops and manufactures medical devices. The private company is based in Swavesey, UK. | Director/Miembro de la Junta | 01/08/2021 |
Formación de Matt Pierce.
The University of Edinburgh | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 4 |
---|---|
Downing Ventures
Downing Ventures Investment ManagersFinance Downing Ventures (Downing Ventures) is an independent venture capital firm founded in 1986. The firm is headquartered in London. | Finance |
Qkine Ltd.
Qkine Ltd. Pharmaceuticals: OtherHealth Technology Qkine Ltd. provides growth factors and bioactive proteins for use in stem cell science and regenerative medicine applications. Its products include Activin A and FGF2. The firm specializes in protein purification, organoids, cytokines, and protein-engineering. The company was founded by Marko Hyvonen and Catherine Elton in 2016 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
LIfT BioSciences Ltd.
LIfT BioSciences Ltd. Miscellaneous Commercial ServicesCommercial Services LIfT BioSciences Ltd. is a pre-clinical stage biotech company based in Brighton, UK. LIfT BioSciences is developing a first-in-class alpha neutrophil cell therapy called N-Lift, which is produced from a patented process using exceptional stem cells, a proprietary enhancement media, and genetic engineering. The therapy is designed to destroy solid tumors both directly and indirectly by turning the tumor microenvironment against the tumor and recruiting the rest of the immune system to destroy it. The British company is working with a range of pharmaceutical license partners across oncology, immunology, neurology, and AMR to develop a portfolio of immune-modulatory alpha neutrophils for treating a range of therapeutic indications, including solid tumors. The company's goal is to deliver complete remission in high unmet need solid tumors before the decade is out. The company was founded in 2014 by Alexander William Blyth, who was inspired to create the company after his mother passed away from pancreatic cancer. | Commercial Services |
TidalSense Ltd.
TidalSense Ltd. Medical SpecialtiesHealth Technology Part of Gas Sensing Solutions Ltd., Cambridge Respiratory Innovations Ltd. develops and manufactures medical devices. The private company is based in Swavesey, UK. | Health Technology |
- Bolsa de valores
- Insiders
- Matt Pierce